{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:03:17Z","timestamp":1793350997083,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51522307"],"award-info":[{"award-number":["51522307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51373167"],"award-info":[{"award-number":["51373167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jconrel.2017.03.391","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T18:32:42Z","timestamp":1490639562000},"page":"23-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma"],"prefix":"10.1016","volume":"254","author":[{"given":"Qing","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2974-1825","authenticated-orcid":false,"given":"Zhigang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiabin","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.03.391_bb0005","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1021\/bm400406x","article-title":"Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel","volume":"14","author":"Joshi","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0968-0896(99)00301-6","article-title":"Paclitaxel esters of malic acid as prodrugs with improved water solubility","volume":"8","author":"Damen","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0015","first-page":"2404","article-title":"Complete regression of well-established tumors using a novel water-soluble poly (l-glutamic acid)-paclitaxel conjugate","volume":"58","author":"Li","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0020","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1021\/ja512616s","article-title":"Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers","volume":"137","author":"Zhang","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2009.09.023","article-title":"pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles","volume":"142","author":"Chen","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8939","article-title":"A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models","volume":"6","author":"Bhattacharyya","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2006.11.014","article-title":"A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer","volume":"117","author":"Xie","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/acs.molpharmaceut.5b00383","article-title":"PEGylated nanoparticles obtained through emulsion polymerization as paclitaxel carriers","volume":"13","author":"Colombo","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0045","doi-asserted-by":"crossref","first-page":"26530","DOI":"10.1021\/acsami.5b07764","article-title":"pH-Sensitive biocompatible nanoparticles of paclitaxel-conjugated poly (styrene-co-maleic acid) for anticancer drug delivery in solid tumors of syngeneic mice","volume":"7","author":"Dalela","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acs.biomac.5b01189","article-title":"Folate receptor targeted delivery of siRNA and paclitaxel to ovarian cancer cells via folate conjugated triblock copolymer to overcome TLR4 driven chemotherapy resistance","volume":"17","author":"Jones","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2012.10.002","article-title":"The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo","volume":"65","author":"Maeda","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2016.08.008","article-title":"PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma","volume":"239","author":"Luo","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0065","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2012.09.006","article-title":"Liposomal paclitaxel formulations","volume":"163","author":"Koudelka","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jconrel.2013.06.017","article-title":"Functionalized nanospheres for targeted delivery of paclitaxel","volume":"171","author":"Bushman","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0075","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jconrel.2015.05.088","article-title":"Dendrimer complexed hydrogel for local delivery of PTX to inhibit recurrence of breast cancer","volume":"213","author":"Hu","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0080","article-title":"Albumin-coated nanocrystals for carrier-free delivery of paclitaxel","author":"Park","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0085","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1021\/acs.chemrev.5b00116","article-title":"Clinical translation of nanomedicine","volume":"115","author":"Min","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0100","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11095-010-0178-7","article-title":"Clinical developments in nanotechnology for cancer therapy","volume":"28","author":"Heidel","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0110","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/adma.201404308","article-title":"An imagable and photothermal \u201cAbraxane-like\u201d nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors","volume":"27","author":"Chen","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0115","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/sj.bjc.6602479","article-title":"NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel","volume":"92","author":"Hamaguchi","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0120","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0125","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1021\/ja513034e","article-title":"Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency","volume":"137","author":"Cai","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0130","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1039\/c3sc50252j","article-title":"Poly (ethylene oxide)-block-polyphosphester-based paclitaxel conjugates as a platform for ultra-high paclitaxel-loaded multifunctional nanoparticles","volume":"4","author":"Zhang","year":"2013","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/anie.201308619","article-title":"pH-responsive micro-and nanocarrier systems","volume":"53","author":"Nowag","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0140","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/smll.201402297","article-title":"Tumor-targeting multifunctional rattle-type theranostic nanoparticles for MRI\/NIRF bimodal imaging and delivery of hydrophobic drugs","volume":"11","author":"Jiao","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0145","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1038\/ncomms4702","article-title":"Poly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapy","volume":"5","author":"Namgung","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0150","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.1021\/jacs.5b03078","article-title":"A nanoparticle cocktail: temporal release of predefined drug combinations","volume":"137","author":"Pathak","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0155","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1039\/C4TB01084A","article-title":"Synthesis and self-assembly of a mikto-arm star dual drug amphiphile containing both paclitaxel and camptothecin","volume":"2","author":"Cheetham","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0160","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1039\/c3cc41896k","article-title":"Supramolecular filaments containing a fixed 41% paclitaxel loading","volume":"49","author":"Lin","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0165","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1021\/ja3115983","article-title":"Supramolecular nanostructures formed by anticancer drug assembly","volume":"135","author":"Cheetham","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0170","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/asia.201501163","article-title":"Amphiphilic cyanine\u2013platinum conjugates as fluorescent nanodrugs","volume":"11","author":"Sun","year":"2016","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0175","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.1073\/pnas.1313459110","article-title":"A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity","volume":"111","author":"Maksimenko","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0180","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/nl061942q","article-title":"Squalenoyl nanomedicines as potential therapeutics","volume":"6","author":"Couvreur","year":"2006","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0185","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1002\/adfm.201501953","article-title":"Self-assembling prodrugs by precise programming of molecular structures that contribute distinct stability, pharmacokinetics, and antitumor efficacy","volume":"25","author":"Wang","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0190","doi-asserted-by":"crossref","first-page":"12835","DOI":"10.1039\/C5CC04164C","article-title":"The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles","volume":"51","author":"Ikuta","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0195","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1039\/C5NR00290G","article-title":"Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis","volume":"7","author":"Yu","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0200","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1021\/acsnano.5b02513","article-title":"Self-monitoring and self-delivery of photosensitizer-doped nanoparticles for highly effective combination cancer therapy in vitro and in vivo","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0205","doi-asserted-by":"crossref","first-page":"19295","DOI":"10.1021\/acsami.5b05347","article-title":"Nanodrug formed by coassembly of dual anticancer drugs to inhibit cancer cell drug resistance","volume":"7","author":"Zhao","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0210","doi-asserted-by":"crossref","first-page":"81499","DOI":"10.1039\/C5RA18586F","article-title":"Small molecular nanomedicines made from a camptothecin dimer containing a disulfide bond","volume":"5","author":"Pei","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0215","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1021\/cr500392w","article-title":"Biomedical applications of supramolecular systems based on host\u2013guest interactions","volume":"115","author":"Ma","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nmat4474","article-title":"Supramolecular biomaterials","volume":"15","author":"Webber","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0225","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1002\/anie.201204596","article-title":"Creation of pure nanodrugs and their anticancer properties","volume":"51","author":"Kasai","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0230","doi-asserted-by":"crossref","first-page":"11748","DOI":"10.1021\/ja505212y","article-title":"Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug\u2013drug conjugate for cancer therapy","volume":"136","author":"Huang","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0235","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1021\/nl502044x","article-title":"Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines","volume":"14","author":"Wang","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0240","first-page":"13503","article-title":"Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release","volume":"7","author":"Zhang","year":"2015","journal-title":"Nano"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0245","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1039\/C5SC03707G","article-title":"A dual-responsive nanocapsule via disulfide-induced self-assembly for therapeutic agent delivery","volume":"7","author":"Lin","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0250","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/app.26236","article-title":"Triblock poly(lactic acid)-b-poly(ethylene glycol)-b-poly(lactic acid)\/paclitaxel conjugates: synthesis, micellization, and cytotoxicity","volume":"105","author":"Xie","year":"2007","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0255","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/poc.919","article-title":"The use of Nile red to monitor the aggregation behavior in ternary surfactant\u2013water\u2013organic solvent systems","volume":"18","author":"Stuart","year":"2005","journal-title":"J. Phys. Org. Chem."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0260","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1039\/c3cc41896k","article-title":"Supramolecular filaments containing a fixed 41% paclitaxel loading","volume":"49","author":"Lin","year":"2013","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0265","doi-asserted-by":"crossref","first-page":"36614","DOI":"10.1038\/srep36614","article-title":"A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic","volume":"6","author":"Zhong","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0270","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.biomaterials.2007.11.029","article-title":"Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel","volume":"29","author":"Zhang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0275","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1002\/adma.201501803","article-title":"Therapeutic enzyme-responsive nanoparticles for targeted delivery and accumulation in tumors","volume":"27","author":"Callmann","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0280","doi-asserted-by":"crossref","first-page":"7272","DOI":"10.1002\/anie.201301397","article-title":"Synthesis of paclitaxel-conjugated beta-cyclodextrin polyrotaxane and its antitumor activity","volume":"52","author":"Yu","year":"2013","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0285","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0290","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1021\/acs.nanolett.6b01632","article-title":"Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy","volume":"16","author":"Luo","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0295","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1002\/smll.201601597","article-title":"Facile fabrication of tumor redox-sensitive nanoassemblies of small-molecule oleate prodrug as potent chemotherapeutic nanomedicine","volume":"12","author":"Luo","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0300","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1021\/bc400210x","article-title":"Novel isoprenoyl nanoassembled prodrug for paclitaxel delivery","volume":"24","author":"Mura","year":"2013","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0305","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1021\/ja806162h","article-title":"Color-tuned highly fluorescent organic nanowires\/nanofabrics: easy massive fabrication and molecular structural origin","volume":"131","author":"An","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1208\/s12249-013-0041-3","article-title":"Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy","volume":"15","author":"Ding","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0315","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1002\/adma.201502022","article-title":"Nanoparticle-loaded protein\u2013polymer nanodroplets for improved stability and conversion efficiency in ultrasound imaging and drug delivery","volume":"27","author":"Lee","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0320","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejpb.2007.03.022","article-title":"Poly(ethylene oxide)\u2013poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs","volume":"66","author":"Chiappetta","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0325","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0330","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1002\/adfm.201604206","article-title":"A sequentially triggered nanosystem for precise drug delivery and simultaneous inhibition of cancer growth, migration, and invasion","volume":"26","author":"Liu","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0335","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.1002\/ange.201503863","article-title":"Hydrophobic cysteine poly (disulfide)-based redox-hypersensitive nanoparticle platform for cancer theranostics","volume":"127","author":"Wu","year":"2015","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0345","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2897","article-title":"Subcellular targeting strategies for drug design and delivery","volume":"9","author":"Rajendran","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0350","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Wood","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0355","doi-asserted-by":"crossref","first-page":"11716","DOI":"10.1002\/ange.201406685","article-title":"Structure-based rational design of prodrugs to enable their combination with polymeric nanoparticle delivery platforms for enhanced antitumor efficacy","volume":"126","author":"Wang","year":"2014","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0360","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1039\/C2CS35265F","article-title":"Design, functionalization strategies and biomedical applications of targeted biodegradable\/biocompatible polymer-based nanocarriers for drug delivery","volume":"42","author":"Nicolas","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0365","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nbt.3212","article-title":"Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index","volume":"33","author":"Lyon","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0370","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tips.2014.09.008","article-title":"Prodrug-based nanoparticulate drug delivery strategies for cancer therapy","volume":"35","author":"Luo","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2017.03.391_bb0375","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0380","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.biomaterials.2012.10.073","article-title":"PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers","volume":"34","author":"Lu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.03.391_bb0385","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.biomaterials.2012.10.029","article-title":"Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel","volume":"34","author":"Luo","year":"2013","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917304959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917304959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:33:03Z","timestamp":1759159983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917304959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":77,"alternative-id":["S0168365917304959"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.391","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}